Dublin, Jan. 03, 2019 (GLOBE NEWSWIRE) -- The "Custom Antibody Market by Service (Antibody Production, Characterization, Immunization, Fragmentation), Type (Monoclonal, Polyclonal, Recombinant), Source (Mouse, Rabbit), Research Area (Oncology, Immunology), and End Users - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The custom antibody market is expected to reach USD 481 million by 2023 from an estimated USD 313 million in 2018, at a CAGR of 8.9%.

Increase in research activities (especially in the life sciences industry), growing industry-academia collaborations, and the expanding antibody therapeutics pipeline are the primary growth drivers for this market. Rapid growth in developing countries across APAC and Latin America and the increasing demand for personalized medicine and protein therapeutics are expected to offer significant growth opportunities for players in this market. However, the need for steep capital investments and long duration of antibody development, along with the increasing focus on antibody alternatives for proteomic studies, are some of the major market challenges.

Antibody production & purification segment to grow at the highest rate during the forecast period.

On the basis of services, the custom antibody market is segmented into antibody development, antibody production & purification, and antibody fragmentation & labeling. The antibody production & purification segment is projected to witness the highest growth in the custom antibody services market during the forecast period. Growth in this segment is largely driven by the need for high-quality antibodies for research reproducibility and generating high-quality therapeutics.

The recombinant antibodies segment is expected to grow at the highest CAGR during the forecast period.

Based on type, custom antibodies are categorized as monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and other custom antibodies. The recombinant antibodies segment is projected to witness the highest growth rate during the forecast period. The increasing development of recombinant antibodies due to their advantages such as batch-to-batch reproducibility, rapid production along with their capability of data reproducibility within research is propelling the growth of this segment during the forecast period.

APAC is projected to witness the highest growth during the forecast period.

Even though North America is expected to account for the largest share of the global custom antibody market in 2018, APAC is expected to witness the highest CAGR during the forecast period. The growing Asian scientific base and capability, growing proteomics and genomics research and increasing research funding, increasing investments by pharmaceutical and biotechnology companies, growing awareness about personalized therapeutics, and increasing research activities in the field of mAb-based therapeutics are factors driving the growth of this regional segment.

Key Topics Covered:

1 Custom Antibody Market: Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency
1.5 Stakeholders
1.6 Limitations

2 Custom Antibody Market: Research Methodology
2.1 Research Approach
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Custom Antibody Market: Executive Summary

4 Custom Antibody Market: Premium Insights
4.1 Custom Antibodies Market: Overview
4.2 Custom Antibodies Market: Geographic Growth Opportunities
4.3 Regional Mix: Custom Antibodies Market (2018-2023)
4.4 Custom Antibodies Market: Developed vs Developing Markets, 2018 vs 2023

5 Custom Antibody Market: Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Research Activity and Funding
5.2.1.2 Quality Concerns Over Catalog Antibodies
5.2.1.3 Increasing Antibody Therapeutics and Expanding Drug Pipeline
5.2.1.4 Growing Industry-Academia Collaborations
5.2.2 Market Opportunities
5.2.2.1 High Growth Opportunities in Emerging Countries
5.2.2.2 Increasing Demand for Personalized Medicine and Protein Therapeutics
5.2.2.3 Growth in Stem Cell and Cvd Research
5.2.2.4 Increasing Focus on Biomarker Discovery
5.2.3 Market Challenges
5.2.3.1 Cost- and Time-Intensive Antibody Development Processes
5.2.3.2 Presence of Antibody Alternatives
5.2.4 Industry Trends
5.2.4.1 Increasing Focus on Antibody-Drug Conjugates (ADCS)
5.2.4.2 Development of Bispecific Antibodies

6 Custom Antibody Market, By Service
6.1 Introduction
6.2 Antibody Development
6.2.1 Antibody Characterization
6.2.1.1 Characterization Eliminates Antibodies With Heterogeneities That May Hamper Research Studies; This is Driving Market Growth
6.2.2 Antigen Preparation
6.2.2.1 Antigen Preparation Forms One of the Most Important Steps in the Antibody Production Process
6.2.3 Immunization & Hybridoma Production
6.2.3.1 Specific Immunization Protocols are Followed Depending on the Antibody Required and Animal Used to Generate Them
6.3 Antibody Production & Purification
6.4 Antibody Fragmentation & Labeling

7 Custom Antibody Market, By Type
7.1 Introduction
7.2 Monoclonal Antibodies
7.2.1 Monoclonal Antibodies to Dominate the Market During the Forecast Period
7.3 Polyclonal Antibodies
7.3.1 Polyclonal Abs are Preferred in Proteomic Research for Detection of Denatured Proteins
7.4 Recombinant Antibodies
7.4.1 Research Reproducibility Offered By These Antibodies is Driving the Growth of the Recombinant Antibodies Segment
7.5 Other Custom Antibodies

8 Custom Antibody Market, By Source
8.1 Introduction
8.2 Mice
8.2.1 Mice are the Most Preferred Hosts for Monoclonal Antibody Production
8.3 Rabbits
8.3.1 Antibodies Developed in Rabbits Eliminate the Limitation of Self-Antigen Recognition in Humans
8.4 Other Sources

9 Custom Antibody Market, By Research Area
9.1 Introduction
9.2 Oncology
9.2.1 Use of Antibodies has Grown Considerably in Cancer Research
9.3 Infectious Diseases
9.3.1 Antibodies are Widely Used in R&D for the Development of Vaccines & Therapeutics Against Various Infectious Diseases
9.4 Immunology
9.4.1 Assessment of Cell Surface Antigens Using Antibodies Forms an Important Field of Research in Immunology
9.5 Neurobiology
9.5.1 Neurobiology Forms One of the Fastest-Growing Segments in Terms of Research Being Undertaken Utilizing Antibodies
9.6 Stem Cells
9.6.1 Availability of High-Quality Antibodies has Boosted Stem Cell Research
9.7 Cardiovascular Diseases
9.7.1 Identification & Characterization of Cvd Biomarkers is an Important Research Area Utilizing Antibodies
9.8 Other Research Areas

10 Custom Antibody Market, By End User
10.1 Introduction
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Pharmaceutical & Biotechnology Companies are the Largest End Users of Custom Antibodies
10.3 Academic & Research Institutes
10.3.1 Increase in DNA Sequencing Studies and Proteomic Research to Drive Market Growth
10.4 Contract Research Organizations
10.4.1 Cros Provide Affordable Outlets for Companies and Academia to Pursue New Medicines and Offer A Cost-Effective Solution to Develop Drugs

11 Custom Antibody Market, By Region
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia Pacific
11.5 Latin America
11.6 Middle East & Africa

12 Custom Antibody Market: Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends
12.3.1 Product & Services Launches
12.3.2 Expansions
12.3.3 Acquisitions
12.3.4 Other Strategies

13 Company Profiles
13.1 Thermo Fisher Scientific Inc.
13.2 Genscript
13.3 Abcam PLC
13.4 Merck Group
13.5 Bio-Rad Laboratories, Inc.
13.6 Cell Signaling Technology, Inc.
13.7 Agilent Technologies, Inc.
13.8 Biolegend, Inc.
13.9 Rockland Immunochemicals Inc.
13.10 Promab Biotechnologies, Inc.
13.11 Proteogenix
13.12 Innovagen Ab

For more information about this report visit https://www.researchandmarkets.com/research/gbzj9x/481_million?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.